… High-flow nasal oxygen therapy (HFNC) may be an attractive … and risk factors for HFNC failure
remain to be determined. … Risk factors for HNFC failure were identified through a landmark …

… COVID-19-related acute hypoxic respiratory failure patients often use high-flow nasal
cannula (HFNO) oxygen therapy. COVID-19 HFNO intubation and mortality risk factors are …

… In this study, the risk factor of failure was higher pCO 2 . Studies to evaluate the PCO 2 level
to discriminate HFNC versus CPAP indications could be useful. Studies interested in HFNC …

… the risk factors for HFNC failure, we used DerSimonian-Laird random-effects models to
pool odds ratios (ORs) and their corresponding 95% CIs. Definitions of the same risk factor …

… To secure favorable results with high-flow nasal cannula (HFNC), the factors related to HFNC
outcomes should be determined. However, the factors associated with failure of HFNC are …

… Patients were included only if they had failed a spontaneous breathing trial or extubation
previously, or had other risk factors for failed extubation (body mass index [BMI] > 30 or left …

… Our findings support that bronchiolitis patients with minimal risk factors have a lower odds
of failing HFNC therapy. Our cohort also includes older patients and non-bronchiolitis patients, …

… During high-flow nasal cannula (HFNC) therapy, flow plays a crucial role in the … flow
settings and subsequent titration. Thus, we aimed to systematically synthesize the effects of flows …

… Moreover, the patients in the present study had more risk factors for reintubation. In addition,
since some investigators advocated an extended period for reintubation for patients under …

… experience with ‘high flows’ delivered using a regular nasal cannula in patients …
oxygen at high flows through a nasal cannula were developed as an alternative to low/intermediate-flow …